Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models
Life · 24.09.2024 · 14 (10) · 1221
DOI: 10.3390/life14101221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 24.09.2024. Verfasst von Renato Spigarelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Geological and Environmental Sciences, University of Bologna, Via Selmi 3, 40126 Bologna, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cristalfarma Srl, Via San Giuseppe Cottolengo, 15, 20143 Milano - Italy., Prof Enzo Spisni, E.S..
Abstract (Originalsprache)
Gastroesophageal reflux disease (GERD) is a digestive disorder that can lead to chronic mucosal damage, causing esophagitis, Barrett’s esophagus and esophageal cancer. GERD currently affects about 13% of the world’s population and represent a major public health concern due to the increasing prevalence and incidence. The aim of this study was to explore complementary strategies for GERD management based the natural compound palmitoylethanolamide (PEA), alone or associated with plant extracts with demonstrated anti-GERD activity (Zingiber officinale, Musa × paradisiaca, Opuntia ficus-indica and Olea europaea). For this purpose, two in vitro models based on the esophageal mucosa CP-B cell line were chosen. The first one was based on the exposure of esophageal cells to HCl, while the second one was based on lipopolysaccharide (LPS) treatment to cause a strong inflammatory cell response. Inflammation induced was assessed using a Luminex® assay, measuring the secretion of IL-1β, IL-6, IL-10, IL-8 and TNF-α. Results obtained demonstrate that PEA strongly decreased the inflammatory response elicited by HCl exposure. Moreover, the effect of PEA was enhanced by the presence of natural extracts of Zingiber officinale, Musa × paradisiaca, Opuntia ficus-indica and Olea europaea. PEA should be considered as an anti-GERD natural compound of interest.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological, Geological and Environmental Sciences, University of Bologna, Via Selmi 3, 40126 Bologna, Italy.
- IBD Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Department of Medical and Surgical and Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Microbiology Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
ORCID-Profile: Renato Spigarelli, Enzo Spisni, Sara Vinciguerra, Ilaria Maria Saracino, Nikolas Kostantine Dussias, Eleonora Filippone
Förderung
- Cristalfarma Srl, Via San Giuseppe Cottolengo, 15, 20143 Milano - Italy.
- Prof Enzo Spisni
- E.S.
- Cristalfarma Srl, Via San Giuseppe Cottolengo
Zitieren
APA
Spigarelli, R., Calabrese, C., Spisni, E., Vinciguerra, S., Saracino, I. M., Dussias, N. K., Filippone, E., & Valerii, M. C. (2024). Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models. Life, 14(10), 1221. https://doi.org/10.3390/life14101221
Vancouver
Spigarelli R, Calabrese C, Spisni E, Vinciguerra S, Saracino IM, Dussias NK, et al. Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models. Life. 2024;14(10):1221. doi:10.3390/life14101221
BibTeX
@article{Spigarelli2024,
author = {Spigarelli, Renato and Calabrese, Carlo and Spisni, Enzo and Vinciguerra, Sara and Saracino, Ilaria Maria and Dussias, Nikolas Kostantine and Filippone, Eleonora and Valerii, Maria Chiara},
title = {Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models},
journal = {Life},
year = {2024},
volume = {14},
number = {10},
pages = {1221},
doi = {10.3390/life14101221}
}
EUVIMED